Bounce Or More Bumps? New China Market Data Offer Bit Of Both
Executive Summary
Two new sets of data on growth in China’s turbulent pharma sector paint a mixed and complex picture, indicating both challenges and opportunities ahead for multinational and domestic firms in the country.